In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

The in vitro antihepadnavirus activities of the purine nucleoside analogs ganciclovir (9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine) and penciclovir [9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; BRL 39123] were compared in primary duck hepatocyte cultures congenitally infected with the duck hepatitis B virus (DHBV). Both compounds inhibited DHBV DNA replication to a comparable extent during continuous short-term treatment of the cultures. However penciclovir was more active both during longer-term continuous treatment (50% inhibitory concentrations: penciclovir, 0.7 +/- 0.1 microM; ganciclovir, 4.0 +/- 0.2 microM) and in washout experiments (50% inhibitory concentrations: penciclovir, 3.0 +/- 0.4 microM; ganciclovir, 46 +/- 1.5 microM) designed to compare the persistence of inhibitory activity after removal of the extracellular compound. The effects on viral protein synthesis were similar to the effects on viral DNA replication. These data suggest that penciclovir or its oral form, famciclovir, may have clinical utility in the treatment of chronic hepatitis B virus infection.

[1]  S. Locarnini,et al.  The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus. , 1993, Antiviral research.

[2]  R. Itoh.  IMP-GMP 5'-nucleotidase. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

[3]  R. Hodge.  Famciclovir and Penciclovir. The Mode of Action of Famciclovir Including Its Conversion to Penciclovir , 1993 .

[4]  D. Earnshaw,et al.  Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus , 1992, Antimicrobial Agents and Chemotherapy.

[5]  D. Coen,et al.  A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells , 1992, Nature.

[6]  M. Chee,et al.  Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir , 1992, Nature.

[7]  S. Eriksson,et al.  Mammalian thymidine kinase 2. Direct photoaffinity labeling with [32P]dTTP of the enzyme from spleen, liver, heart and brain. , 1992, European journal of biochemistry.

[8]  E. De Clercq,et al.  Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus. , 1991, The Journal of biological chemistry.

[9]  R. Fautz,et al.  Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). , 1991, Mutation research.

[10]  S. Bowden,et al.  Inhibition of Duck Hepatitis B Virus Replication in vivo by the Nucleoside Analogue Ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] Guanine) , 1991 .

[11]  P. Marion.  Development of antiviral therapy for chronic infection with hepatitis B virus. , 1991, Current topics in microbiology and immunology.

[12]  S. Locarnini.  Design of new anti‐viral agents for chronic hepatitis B virus infection , 1991, Journal of gastroenterology and hepatology.

[13]  J. Summers,et al.  Viral DNA synthesis. , 1991, Current topics in microbiology and immunology.

[14]  M. Currens,et al.  Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine. , 1990, Biochemical and biophysical research communications.

[15]  Shinobu,et al.  Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro , 1990, Antimicrobial Agents and Chemotherapy.

[16]  I. Gust,et al.  Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compounds , 1990, Journal of medical virology.

[17]  S. Locarnini,et al.  Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model , 1990, Journal of medical virology.

[18]  S. Locarnini,et al.  INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDS , 1989, The Lancet.

[19]  D. Sutton,et al.  Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir] , 1989, Antimicrobial Agents and Chemotherapy.

[20]  A. Fridland,et al.  Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells. , 1989, Molecular pharmacology.

[21]  D. Tyrrell,et al.  Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides. , 1988, Biochemical and biophysical research communications.

[22]  D. Sutton,et al.  Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture , 1987, Antimicrobial Agents and Chemotherapy.

[23]  O. Yokosuka,et al.  Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection , 1987, Hepatology.

[24]  J. Summers,et al.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus , 1986, Journal of Virology.

[25]  P. Keller,et al.  Cytoplasmic 5'-nucleotidase catalyzes acyclovir phosphorylation. , 1985, The Journal of biological chemistry.

[26]  D. Smee,et al.  Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase , 1985, Antimicrobial Agents and Chemotherapy.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[28]  J. D. Karkas,et al.  Activation by thymidine kinase and potent antiherpetic activity of 2'-nor-2'-deoxyguanosine (2'NDG). , 1982, Biochemical and biophysical research communications.

[29]  P. H. Ellims,et al.  Human liver thymidine kinase. Purification and some properties of the enzyme. , 1980, Journal of Biological Chemistry.